A three-level model of cognitive processing to account for complex monitoring when individuals are faced with ill-structured problems, i.e., problems on which opposing or contradictory evidence and opinion exists, is proposed. At the first level, cognition, individuals compute, memorize, read, perceive, solve problems, etc. At the second, metacognitive level, individuals monitor their own progress when they are engaged in these first-order tasks. At the third level, epistemic cognition, individuals reflect on the limits of knowing, the certainty of knowing, and criteria of knowing. Epistemic assumptions influence how individuals understand the nature of problems and decide what kinds of strategies are appropriate for solving them. While cognitive and metacognitive processes appear to develop in childhood and are used throughout the life span, current research on adult reasoning suggests that epistemic cognitive monitoring develops in the late adolescent and adult years.

Keywords:
Adult development, Cognitive development, Cognitive processes, Dialectics, Epistemolog, Metacognition
This content is only available via PDF.
© 1983 S. Karger AG, Basel
1983
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.